Abstract. It is believed that amyloid-␤ peptide (A␤), in its aggregated-oligomeric state, constitutes one of the neurotoxic factors involved in the pathogenesis of Alzheimer's disease. With the objective of studying a potential role of the peptide on synaptic transmission, we studied the effect of soluble A␤ 1-40 on synaptic transmission in rat hippocampal neurons. Neurons incubated with 500 nM of A␤ 1-40 peptide for 3 days presented higher levels of intracellular calcium transients, as evaluated by fluorimetric techniques. These effects of A␤ were time and concentration dependent and were accompanied by increases in glutamatergic (0.8 ± 0.2 Hz to 2.9 ± 0.6 Hz), but not GABAergic, transmission. The analysis of pharmacologically isolated currents in treated neurons showed increases in both AMPA-and NMDA-mediated currents as compared to control. The effects of the peptide on the frequency of synaptic currents correlated well with increases in the number of SV2 puncta and of FM1-43 destaining, suggesting a presynaptic locus for the peptide. The data also shows that application of either A␤ or bicuculline alone for 24 h was without effects on neurotransmission. However, their co-application induced an increase in synaptic transmission which was accompanied by synchronous discharges reminiscent to those produced by pro-convulsive drugs, such as bicuculline. In conclusion, these results suggest that the soluble form of A␤ 1-40 participates in the regulation of synaptic transmission increasing excitability and producing a pre-epileptogenic state in hippocampal neurons.
INTRODUCTION
Alzheimer's disease (AD) is a progressive dementia characterized by a deficiency in learning and memory. One of the characteristics of this disease is the presence of extracellular senile plaques principally composed of aggregated species of amyloid-␤ peptide (A␤), a 39 to 42 amino acid peptide produced by the cleavage action of ␤ and ␥ secretases on the amyloid-␤ protein precursor (A␤PP). The oligomeric and aggregated states of A␤ have been implicated in the synaptotoxicity and neurodegeneration found in the brain of AD patients [1, 2] . It has been demonstrated that aggregated A␤ inhibits synaptic plasticity and decreases long term potentiation (LTP) and dendritic spine density in rat hippocampal slices [3] [4] [5] [6] . Interestingly, these effects do not occur in presence of the monomeric form of the peptide [7, 8] , and studies in rat hippocampal slices showed that a low concentration of the peptide can facilitate LTP [9] . In addition, it was shown that soluble A␤ promotes neurogenesis in neural stem cells increasing the expression of neuronal markers such as NeuN and Tuj1 [10] . Overall, these results suggest that less aggregated forms of A␤ might have neurotrophic effects on the central nervous system. Therefore, in order to elucidate the role of these more soluble forms of A␤ on synaptic transmission, we evaluated the effects of A␤ on synaptic function in hippocampal neurons. The neurons treated with the soluble form of A␤ (A␤ s1-40 ) for 72 h showed that the peptide facilitates synaptic transmission, increasing the immunoreactivity for SV2, a synaptic vesicle protein, and glutamatergic neurotransmission, leading to an in vitro pre-convulsive state contrary to that reported with the oligomeric forms of the peptide.
MATERIALS AND METHODS

Rat hippocampal cultures
Sprague Dawley rats were treated and manipulated according to the ethical guide for the use and care of experimental animals established by NIH (NIH, Maryland, USA) and the Ethic Committee at the University of Concepcion. Female rats pregnant with 18-19 day old embryos were euthanized. The embryos were removed and the hippocampi dissected. The neurons were dissociated enzymatically and mechanically and plated at a density of 350,000 cells/ml on 35 mm coverglass slips coated with poly-L-lysine (0.25% P/V; MW > 350 kDa, Sigma, USA). The cultures were maintained at 37ºC with 5% CO 2 , and the culture medium consisting of 90% minimal essential media (MEM, GIBCO, Rockvile, USA), 5% horse serum (Hyclone), 5% fetal bovine serum and N3 (a mixture of nutrients) was replaced every 3 days. Chronic treatment (24-72 h) with soluble peptide (A␤ s1-40 , 0.1-1 M) was done on neurons having 8-9 days in vitro (DIV) and similar results were obtained with older neurons (17 DIV) . Unlike longer applications, acute applications (min-hr) of A␤ s1-40 did not produce any noticeable effects on synaptic transmission or intracellular calcium.
Peptide preparation
Human A␤ peptide was purchased from Tocris (MO, USA). A␤ and the reverse peptide A␤ were dissolved in dimethyl sulfoxide (DMSO) at a concentration of 10 mg/ml and immediately stored in aliquots at −20ºC until its use. For the preparation of A␤ oligomers/aggregates (80 M), aliquots of peptide stock (250 g in 25 l of DMSO) were added to 700 l of PBS (Gibco, USA) and stirred continuously in a vertical manner (200 RPM at 37ºC) for 90 min and stored at 4ºC. A␤ peptide aggregation was followed by turbidity measurements (O.D. 405 nm). Final products of aggregation assays were kept at 4ºC until a particular experiment.
Whole cell patch clamp
Tissue culture media was replaced with an external solution containing (in mM): 150 NaCl, 5.4 KCl, 2.0 CaCl 2 , 10 glucose and 10 HEPES (pH 7.4). The internal solution of the recording pipet contained (in mM): 120 KCl, 2.0 MgCl 2 , 2 ATPNa 2 , 10 BAPTA, 0.5 GTP, 10 HEPES (pH 7.4). Electrodes were made using borosilicate capillaries (WPI, Sarasota, FL) on a horizontal puller (Sutter Instruments, Novato, CA). The pipette and series resistances were 4 and 10 M , respectively. The series resistance was continuously monitored and cells were discarded if the resistance increased by more than 15%. The membrane potential was adjusted to −60 mV and the data was displayed and stored using a 1322A Digidata acquisition board (Axon Instruments, Inc.) and analyzed with electrophysiological software (pClamp9, Axon Instruments, Inc.). At this holding potential, excitatory (cationic driven) and inhibitory (anionic driven) currents were inward and displayed higher amplitudes facilitating the analysis since their reversal potentials were near 0 mV. Changes in synaptic currents were detected using the whole cell patch clamp technique as previously described [11] with an Axopatch-200B amplifier (Axon Instruments, Inc., Burlingame, CA) and an inverted microscope (Nikon, Eclipse, TE200-U, Japan). In order to study miniature synaptic currents (mEPSCs and mIPSCs), TTX (50 nM) was added to inhibit action potentials. Fresh stock solutions were prepared weekly in deionized-distilled water and kept refrigerated at 4ºC. In order to rapidly apply the ligands, we used an array of external tubes (200 m in internal diameter) which was placed to within 50 m from the neuron. The solutions containing the ligands flowed continuously from the tubes by gravity. To obtain pharmacologically isolated neurotransmissions, we used bicuculline (5 M) to block GABA A receptors, CNQX (4 M) for AMPA receptors, and AP-V (50 M) for NMDA receptors (Tocris Bioscience, MO, USA).
Intracellular calcium fluorimetry
Neurons were loaded (30 min, 36. . In order to visualize the binding of the primary antibody to the neurons, the cells were incubated with a second antibody from goat conjugated to Cy3 for MAP-2 and FITC for SV2 (1 : 200; Jackson ImmunoResearch Laboratories, West Grove, PA). Finally, the cells were mounted onto slides using Dako Fluorescent Mounting Media (Dako, North America, Inc, CA, USA) and the images were obtained using a Nikon confocal microscope (60X water immersion objective, Nikon, Tokyo, Japan).
Triethylammonium(propyl)-4-(2-(4-dibutylaminophenyl)vinyl)pyridinium (FM1-43) loading and unloading
FM1-43 (15 mM; Molecular Probes, Eugene, OR, USA) was loaded in presynaptic terminals of control neurons and neurons treated with A␤ s1-40 incubated in a high potassium solution (30 mM) for 5 min at room temperature [12] . The loading was dependent on extracellular calcium and TTX, indicating a complete dependence on synaptic vesicle recycling. After washing with external solution for 10 min, discharge was induced from the active zones by rapid perfusion of a high potassium solution (30 mM) to the bath [13] . Higher concentrations of KCl were avoided since they were associated to slow and partial recoveries on the reuptake of FM1-43. The FM1-43 emission was obtained using an inverted microscope (Eclipse TE, Nikon, Melville, NY, USA) equipped with an oil immersion objective (100X NA 1.45), long-pass filters (>510 nm) and a Sensicam CCD camera (PCO, Kelheim, Germany). The FM1-43 fluorescence intensity was measured continuously during 5 min using an area of 2X2 pixels. All intensity values were analyzed using the Imaging Axon Workbench 2.2 program (Axon instruments).
Immunogold labeling for Aβ and Aβagg Soluble and aggregated A␤ were adsorbed onto nickel grids covered by carbon-stabilized Formvar film and air-dried. After washing in buffer (PBS 1X, pH 7.4) for 2 min, nonspecific binding was blocked by incubation with 3% ovalbumin in PBS 1X pH 7.4, for 1 h. The grids were then placed on a droplet of anti-A␤ 1 : 500 (Santa Cruz Biotechnology, CA, USA) in PBS (pH 7.4) with 3% ovalbumin, incubated at 4 • C overnight, and passed under five droplets of washing solution (PBS 1X, pH 7.4, with 0.05% Tween 20) for 5 min each time. A droplet of anti-rabbit IgG conjugated to 10 nm colloidal gold particles for 1 h (Sigma; diluted 1 : 20 PBS, pH 7.4, with 3% ovalbumin) was added and washed [14] . Before final examination under a JEOL 100-B electron microscope, the specimens were negatively stained with 2% uranyl acetate in water (Fig. 2) .
Thioflavine-S staining
A␤ soluble and aggregates were stained with thioflavine-S (ThS, 0.5% w/v) for 10 min at 22-24 • C. ThS fluorescence was acquired after exciting the samples at 488 nm.
Western blots
Standard Western blotting procedures were followed [15] . Equal amounts of protein were separated on 10-12% SDS-PAGE gels. Protein bands were transferred onto nitrocellulose membranes, blocked with 5% low fat milk, and incubated with anti-A␤ 1 : 500 (Santa Cruz Biotechnology, CA, USA). Immunoreactive bands were visualized with ECL Plus Western Blotting Detection System (PerkinElmer, MA, USA).
Dot blot
A␤ was diluted to 0.5 M in culture media and samples of 100 l were taken at various times of incubation (0-72 h). The samples were centrifuged at 10,000 rpm for 15 min to separate supernatant and pellet and applied onto nitrocellulose membranes. Non specific binding was blocked with non fat milk before incubation with anti-A␤ 1 : 500 (Santa Cruz Biotechnology, CA, USA).
Charge transfer analysis
Charge transfer was calculated by integration of membrane currents using the area under the curve of synaptic events pharmacologically isolated.
Data analysis
Experiments were carried out in parallel sister cultures in order to reduce the variability between control and treated neurons. Control cells were incubated with 0.1% DMSO in order to show that the solvent had no effect on the neurons. The data was obtained from at least 3 distinct experiments. The results are expressed as mean ± SEM (standard error mean). Statistical analysis was done using Student's t test or ANOVA followed by the Bonferroni post test. ( * ) p < 0.05 was considered statistically significant, ( * * ) p < 0.01, ( * * * ) p < 0.005.
RESULTS
The soluble form of the Aβ peptide facilitates neurotransmission in hippocampal neurons
The oligomeric forms of the A␤ peptide have been described as factors responsible for the neurodegeneration observed in patients with AD [16, 17] . This deterioration has been associated to the depression in glutamatergic neurotransmission with consequent modifications in functional and structural synaptic plasticity, also leading to loss of synapses and memory in rodent AD models, as well as humans [18, 19] . However, the function of the monomeric and simpler forms of A␤ in synaptic activity and long term potentiation (LTP) are still largely unknown [7, 20] . In the present study, rat hippocampal neurons were incubated for 72 h with increasing concentrations of soluble A␤ s1-40 (0.1-1 M), and the frequency of intracellular calcium transients were evaluated using the fluorescent indicator Fluo-4AM (Fig. 1A) . The data in Fig. 1A shows that the soluble form of A␤ increased the frequency of intracellular calcium transients in a concentrationdependent manner that was statistically significant from control at 0.5 M (0.06 ± 0.004 Hz, n = 99 cells; vs 0.08 ± 0.004 Hz, n = 126; p<0.05). Lower concentrations did not produce any effect on neuronal activity at 72 h. On the other hand, neurons treated with the same concentration of the aggregated form of the A␤ 1-40 peptide for 24 h displayed a marked decrease in the frequency of calcium transients (0.023 ± 0.003 Hz, n = 136, p < 0.001, Fig. 1A ). These data are in agreement with results recently published and show that soluble and aggregated forms of A␤ have different activities [7, 20] . In addition, patch clamp experiments done to evaluate synaptic currents using the same conditions as above demonstrated the same trend, with the soluble peptide significantly increasing the frequency of these events, whereas aggregated A␤ produced a decrease (Fig. 1B) . On the other hand, cultures chronically incubated with the A␤ 40-1 reverse peptide or with acute applications of A␤ showed no effect in synaptic transmission (Fig. 1C) . The modification in synaptic transmission by chronic A␤ s1-40 was likely produced by non-aggregated forms of the peptide. Ultra structural and biochemical analysis of the soluble peptide with electron microscopy ( Fig. 2A-C) , ␤-sheets detecting thioflavin-S (Fig. 2D) , Western blot and dot blots showed significant differences to the pre-aggregated form, composed of fibrillar/amyloid structures found in the pellet fraction (Fig. 2E, F) .
In order to determine the time course of the positive effects of A␤ on neuronal activity, electrophysiological recordings of overall miniature synaptic activity were carried out at different incubation times. The data revealed a time-dependent increase in the levels of synaptic current frequency with statistically significant effects only at 72 h of treatment with the peptide, compared with parallel sister cultures having the same developmental age (Fig. 3A) . The treatment produced alterations in miniature current amplitude, 36 ± 3 pA (n = 20) for control and 24 ± 3 pA (n = 19, p < 0.05) for A␤. Analysis of pharmacologically isolated glutamatergic synaptic currents showed that they were significantly increased by A␤ (Fig. 3B) , without significant changes in the amplitude (29 ± 4 pA vs 21 ± 2 pA, p > 0.05). Next, we wanted to determine if these increases in synaptic current frequency were accompanied by morphological changes and if they were dependent on the time of incubation. For this, changes in a presynaptic component were analyzed using an antibody that recognizes SV2, a synaptic vesicle protein, and was quantified by counting the number of immunoreactive puncta for 20 m of primary process in hippocampal neurons treated for 72 h with A␤ s1-40 . Analysis of the effect produced by A␤ s1-40 at different times of exposure (12-72 h) is shown in Fig. 4 . The quantitative immunofluorescent analysis of confocal images (Fig. 4A, B) revealed that A␤ 1-40 produced a sustained increase in SV2 staining with time and was statistically significant at 72 h (7.8 ± 0.65 puncta/20 m vs 14.2 ± 1.05, p < 0.01). To determine if the increase in SV2 was accompanied by a functional increase in synaptic release upon presynaptic depolarization with high K + , we carried out experiments using the fluorescent probe FM1-43 (Fig. 4C) , a functional synaptic marker having an amphipatic nature that interacts with the lipid component of the membrane through its hydrophobic region [21] . Control and A␤ 1-40 treated neurons were charged with FM1-43 and subsequently exposed to a pulse of high potassium solution which caused a decrease in the measured fluorescence. The concentration of 30 mM K + was chosen because it has been shown that it depolarizes the presynaptic terminal sufficiently enough to produce an increase in the frequency of miniature currents [22] and the release of synaptic vesicles loaded with FM1-43 [11] . Additionally, a group of neurons treated with the reverse peptide showed no differences to control neurons in FM destaining which is in agreement with the lack of synaptic activity of this form (Fig. 4D) .
The data showed that after treatment with A␤ s1-40 , hippocampal neurons displayed a faster decay of fluorescence associated to FM1-43 (Fig. 4D) and 0.94 ± 0.01 (p < 0.01) for neurons treated with A␤ s1-40 . In addition, the fluorescent decay constant value for control neurons was 61 ± 4.8 s, which was significantly higher than in neurons treated with the soluble peptide (39 ± 4.4 s; n = 3, p < 0.01, Fig. 4D ). Taken together, these results suggest that nanomolar concentrations of soluble A␤ 1-40 can positively modify presynaptic components, thus facilitating synaptic neurotransmission. Quantification of SV2 punctaes in age-matched neurons showed an increase at 11 and 20 DIV neurons after 72 h of A␤ s1-40 treatment (Fig. 5A, B) .
Effects of Aβ s1-40 on pharmacologically isolated synaptic transmissions
We then evaluated the effect of A␤ on miniature excitatory and inhibitory synaptic activities, mEPSC, and mIPSC, respectively. To accomplish this, miniature synaptic currents associated to AMPA, NMDA, and GABA A receptors were pharmacologically isolated (see Methods). Analysis of electrophysiological recordings indicated that A␤ s1-40 significantly increased the frequency of currents associated to AMPA receptors from 0.56 ± 0.21 Hz (n = 5) to 1.65 ± 0.20 Hz after 72 h of A␤ s1-40 0.5 M (n = 8) (p < 0.01), without changes in the time constant of decay (5.20 ± 0.7 ms, n = 5 and 4.5 ± 0.4 ms, n = 11) or peak amplitude of these fast excitatory currents (Fig. 6A, D) . Figure 6E shows electrophysiological recordings of miniature NMDA synaptic activity isolated in the presence of a cocktail of inhibitors for AMPA-R and GABA A -R, 4 M CNQX, and 5 M bicuculline, respectively. The acute application of 50 M AP-V resulted in a complete blockade of these synaptic currents, confirming that these low amplitude currents corresponded to synaptic events associated to the NMDA-R (Fig. 6E, lower trace) . Subsequently, the properties of these synaptic currents were analyzed and the values of frequency and peak amplitude were compared in both conditions (Fig. 6F, G) . Of these parameters, we found that the frequency of miniature NMDA synaptic currents was significantly increased (Fig. 6F) . Furthermore, applications of NMDA to the postsynaptic membrane revealed that the current density induced by activation of NMDA receptors was not significantly affected by A␤ (Fig. 6 H) . Evaluation of the GABAergic inhibitory activity, on the other hand, showed no significant variations in the frequency (0.63 ± 0.14 Hz, n = 11 vs 0.55 ± 0.13 Hz, n = 9).
The previous results suggest that the soluble form of the A␤ 1-40 peptide at nanomolar concentrations induces selective facilitation of glutamatergic neurotransmission. Since it is widely known that the activation of excitatory receptors can produce an increase in calcium permeability, we decided to examine if the frequency of intracellular calcium transients, and associated AMPA or NMDA receptors, could be altered after treatment with the soluble peptide. Therefore, we analyzed calcium transients in the presence of 50 M AP-V or 4 M CNQX acutely applied and the percentage of inhibition evoked by the acute blockade was obtained (Fig. 7A) . The results demonstrated that treatment with the soluble form of the A␤ 1-40 peptide induced a significant increase in the percentage of inhibition by AP-V, but not by CNQX, suggesting that A␤ s1-40 facilitates the NMDA-type phenotype at the network level (57 ± 4% vs 88 ± 4%, p < 0.05, Fig. 7B ).
The data previously presented suggest that the soluble form of the A␤ 1-40 peptide facilitates glutamatergic transmission, previously shown to support neuronal connectivity and excitability that can be associated to LTP [23, 24] , learning and memory [25] [26] [27] . Also, it has been reported that high levels of glutamatergic activity sustained for a long time can induce excitotoxicity and pre-convulsive states affecting network homeostasis [28, 29] . Therefore, the following question arises: Is it possible that, aside from increasing excitatory transmission, the soluble form of the A␤ peptide has pro-convulsive activity?
Aβ s1-40 facilitates generation of pre-convulsant activity in vitro
To answer the previous question, we employed a paradigm used to study the potential of a variety of compounds to induce pro-epileptogenic activity [30] . For example, the pro-convulsant action of bicuculline, a competitive antagonist of GABA A receptors, has been well documented [31, 32] . Hippocampal neurons cultured with 5 M bicuculline showed increases in neuronal excitability and bursting activity (Fig. 8C,  inset) . This excitation resulted from the blockade on inhibition and was mainly produced by an increase in AMPA transmission [30, 33] . On the other hand, a lower concentration of bicuculline (1 M) was unable to induce such a state of overt hyperactivity (Fig. 8A) . For example, analysis of spontaneous and pharmacologically isolated miniature synaptic currents revealed that there was no significant increase in the frequency of overall synaptic currents and those mediated by NMDA, AMPA, and GABA A (data not shown). After determining that neither A␤ nor bicuculline, applied for 24 h, produced hyper excitability, we evaluated if their co-incubation was able to increase synaptic transmission. To assess this point, we compared the spontaneous synaptic activity obtained under these conditions. Neurons co-incubated with A␤ and the GABA A receptor antagonist showed more spontaneous postsynaptic currents (1.7 ± 0.2 vs 5.1 ± 0.8 Hz) than control neurons or those treated with A␤ s1-40 or bicuculline alone (Fig. 8C) . Additionally, quantification of synaptic events in presence of a cocktail to detect NMDA currents showed that co-incubation with soluble A␤ 1-40 peptide and bicuculline produced an increase in current frequency (0.4 ± 0.1 vs 1.8 ± 0.1 Hz, NMDA (n = 5), * * p < 0.01, Fig. 8B, D) . Analysis of charge transfer during the synaptic currents also showed that the combination of A␤ and bicuculline increased the function of AMPA and NMDA receptors (Fig. 8E, F, p < 0.05) . Furthermore, analysis of immunoreactivity associated to SV2, under the same conditions, revealed an increase in the fluorescence for this presynaptic marker that correlated with the increase in frequency (Fig. 9) . A␤ peptide is secreted by several cell types explaining its presence, at picomolar concentration, in plasma and cerebral spinal fluid [34] . However, the functional relevance of A␤ formation in the brain is still under investigation. Existing evidence supports its action in the maintenance of neuronal survival. For example, it was demonstrated that incubation of neuron cultures with ␤ or ␥ secretase inhibitors induced neuronal death [35] , a phenomenon that was reversed by incubation with low concentrations of A␤ . However, the mechanism by which A␤ regulated this survival process is not understood.
DISCUSSION
Facilitation of glutamatergic neurotransmission mediated by the soluble form of Aβ
In agreement with a neurotrophic action, we report that A␤ s1-40 facilitates synaptic transmission and increases the frequency of intracellular calcium transients. Although the concentration of A␤ used was above its reported value in the brain [34] , it is justified to accelerate its effects in our working in vitro cellular model. In addition, it is likely that the concentration of A␤ at the synaptic cleft is much higher than in plasma or cerebral spinal fluid thus allowing its nucleation and subsequent aggregation. Although it was reported that A␤ clearance from CSF and blood in normal individuals has a time course of only a few hours [36] , we believe that this does not contradict our interpretation that synaptic A␤ reaches a higher concentration in the synaptic cleft to exert its physiological and pathological actions. It is very well accepted that A␤ will accumulate and eventually cause brain damage [37] .
Since previous studies have shown that augmentations in intracellular calcium are related to increases in neuronal excitability and therefore to network connectivity [38] , we can hypothesize that soluble A␤ increases network excitability. Distinctly, this action was divergent to that of aggregated A␤ , which under similar conditions displayed inhibitory effects (Fig. 1) . This supports the conclusion that soluble and aggregated forms of A␤ have differential actions at the synapses. Additionally, A␤ was not extensively aggregated [39] at the nanomolar concentrations used in our experiments, a conclusion that was largely confirmed by ultra structural and biochemical results (Fig. 2) . Additionally, the time course of the soluble A␤ effects on synaptic transmission found in this study are different to those reported using protofibrils and a neprelysin inhibitor [40, 41] and this is likely due to the A␤ forms and differences in the experimental models used in the studies. While in the first study, protofibrils might be increasing activity by disrupting the cell membrane [11] , the pharmacological blockade of peptidases in the second study would increase synaptic release by accelerating the onset of A␤ actions. In any case, less aggregated forms of A␤ facilitate synaptic release.
The increase in intracellular calcium transients correlated well with the augmentation in miniature synaptic currents suggesting that A␤ increases network excitability augmenting the release of neurotransmitters. The finding that A␤ increases glutamatergic transmission is in agreement with previous studies showing that A␤ can enhance the concentration of extracellular glutamate by interfering with glutamate transporters in cultured cortical neurons and glia [42] . We also found an increase in the immunoreactivity associated with SV2 that was maintained in time and statistically significant after 72 h. Additionally, experiments to evaluate neurotransmitter exocytosis by means of FM1-43 fluorescence destaining revealed that neurotransmitter release was significantly higher in neurons treated with A␤ s1-40 . Altogether, these results demonstrate that incubation of hippocampal neurons with A␤ s1-40 induces a phenomenon of synaptic facilitation that stimulates presynaptic release. Interestingly, the amplitude of the synaptic currents was smaller in the treated neurons and this might reflect a reduced density of postsynaptic receptors, as opposed to the presynaptic regions enhanced by A␤. The overall effect of A␤, nevertheless, is an increase in synaptic transmission as correlated to enhancements in calcium transients, repetitive firings and synaptic transfer charge. This study also showed a significant increase in AMPAergic and NMDA mEPSC frequencies after Fig. 9 . Effect of combined A␤ s1-40 and bicuculline on SV2. Confocal microscopy shows immunoreactivity associated to MAP2 (Cy3, Red) and SV2 (FITC, green) obtained in hippocampal neurons in control condition and after the indicated treatments. Channel superposition is shown at the left while the immunoreactivity associated to each channel in each condition is shown separately. Size of calibration bar is 10 m. chronic treatment. Furthermore, calcium fluorimetry analysis indicated that A␤ s1-40 induced the appearance of a glutamatergic NMDA-like phenotype that through activation of signaling pathways likely participate in synaptic remodeling [43, 44] . We are currently examining potential mechanisms for this synaptic facilitation.
Aβ s1-40 facilitates the generation of pro-convulsant activity
The present data indicate that the soluble form of A␤ enhances neuronal connectivity, events that have been implicated in learning and memory processes, but also in excitotoxicity [28, 45, 46] . Therefore, is it possible that these effects of A␤ lead hippocampal neurons to a pro-convulsant-like behavior? This question was answered using a classic paradigm which blocks GABAergic activity leading to an increase in neuronal excitability that leads to epileptogenesis [47] [48] [49] . Co-incubation with A␤ s1-40 and bicuculline, at concentrations that are not active alone, produced an increase in the frequency of excitatory synaptic transmission as well as repetitive firing activity. Evaluation of pharmacologically isolated synaptic activity revealed that the transfer charge of NMDA mEPSCs was significantly increased (Fig. 8D) , suggesting increased excitation and synaptic plasticity [50] . In addition, the analysis of SV2 demonstrated that co-incubation of A␤ s1-40 and bicuculline increased this presynaptic protein.
These results show that A␤ facilitates glutamatergic transmission, which has been documented as important for epileptogenesis and pro-convulsant activity [51] . Our results agree with experiments showing that overexpression of A␤ in transgenic mice produced epileptiform activity in the hippocampal-cortex enthorinal circuit [52] , and it is possible that these electrical alterations in the brain could lead to impairments in memory and learning in AD.
Regarding the potential mechanism by which soluble A␤ enhances synaptic activity, we believe that intracellular signaling activated by calcium is important. Our preliminary results show that the effect of A␤ was inhibited by KN-62 suggesting the involvement of CaMK-IV and initiated by AMPA and NMDA receptors (Cuevas, unpublished results). This is in agreement with the role of calcium on synaptic plasticity previously suggested [53] .
Therefore, based on the above, we suggest that A␤ , in simple non-aggregated forms, induces synaptic facilitation of glutamatergic transmission. This could lead to a pre-convulsive condition and probably to alterations in the homeostasis of neuronal network, a phenomenon that has been widely documented in AD [52, 54] . Nevertheless, the mechanisms that originate these changes and the targets of A␤ in the membrane still need to be determined.
